Literature DB >> 17090721

Lobe and Serrate are required for cell survival during early eye development in Drosophila.

Amit Singh1, Xiao Shi, Kwang-Wook Choi.   

Abstract

Organogenesis involves an initial surge of cell proliferation, leading to differentiation. This is followed by cell death in order to remove extra cells. During early development, there is little or no cell death. However, there is a lack of information concerning the genes required for survival during the early cell-proliferation phase. Here, we show that Lobe (L) and the Notch (N) ligand Serrate (Ser), which are both involved in ventral eye growth, are required for cell survival in the early eye disc. We observed that the loss-of-ventral-eye phenotype in L or Ser mutants is due to the induction of cell death and the upregulation of secreted Wingless (Wg). This loss-of-ventral-eye phenotype can be rescued by (i) increasing the levels of cell death inhibitors, (ii) reducing the levels of Hid-Reaper-Grim complex, or (iii) reducing canonical Wg signaling components. Blocking Jun-N-terminal kinase (JNK) signaling, which can induce caspase-independent cell death, significantly rescued ventral eye loss in L or Ser mutants. However, blocking both caspase-dependent cell death and JNK signaling together showed stronger rescues of the L- or Ser-mutant eye at a 1.5-fold higher frequency. This suggests that L or Ser loss-of-function triggers both caspase-dependent and -independent cell death. Our studies thus identify a mechanism responsible for cell survival in the early eye.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090721     DOI: 10.1242/dev.02686

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  31 in total

1.  Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.

Authors:  J-H Zhang; L M Panicker; E M Seigneur; L Lin; C D House; W Morgan; W C Chen; H Mehta; M Haj-Ali; Z-X Yu; W F Simonds
Journal:  Cell Death Differ       Date:  2010-03-26       Impact factor: 15.828

2.  Wingless signaling in Drosophila eye development.

Authors:  Kevin Legent; Jessica E Treisman
Journal:  Methods Mol Biol       Date:  2008

3.  Inhibition of Daughterless by Extramacrochaetae mediates Notch-induced cell proliferation.

Authors:  Carrie M Spratford; Justin P Kumar
Journal:  Development       Date:  2015-05-14       Impact factor: 6.868

4.  The Classic Lobe Eye Phenotype of Drosophila Is Caused by Transposon Insertion-Induced Misexpression of a Zinc-Finger Transcription Factor.

Authors:  Wonseok Son; Kwang-Wook Choi
Journal:  Genetics       Date:  2020-07-08       Impact factor: 4.562

Review 5.  Drosophila as a Potential Model for Ocular Tumors.

Authors:  Daimark Bennett; Ekaterina Lyulcheva; Neville Cobbe
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

6.  Inhibition of RNA interference and modulation of transposable element expression by cell death in Drosophila.

Authors:  Weiwu Xie; Chengzhi Liang; James A Birchler
Journal:  Genetics       Date:  2011-05-19       Impact factor: 4.562

Review 7.  The fly eye: Through the looking glass.

Authors:  Justin P Kumar
Journal:  Dev Dyn       Date:  2017-10-23       Impact factor: 3.780

8.  Domain specific genetic mosaic system in the Drosophila eye.

Authors:  Meghana Tare; Oorvashi Roy Puli; Michael T Moran; Madhuri Kango-Singh; Amit Singh
Journal:  Genesis       Date:  2012-11-26       Impact factor: 2.487

9.  The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.

Authors:  Noriko Oshiro; Rinako Takahashi; Ken-ichi Yoshino; Keiko Tanimura; Akio Nakashima; Satoshi Eguchi; Takafumi Miyamoto; Kenta Hara; Kenji Takehana; Joseph Avruch; Ushio Kikkawa; Kazuyoshi Yonezawa
Journal:  J Biol Chem       Date:  2007-05-21       Impact factor: 5.157

10.  Position dependent responses to discontinuities in the retinal determination network.

Authors:  Claire L Salzer; Justin P Kumar
Journal:  Dev Biol       Date:  2008-11-14       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.